It was all over the news today. Colombia is taking the war on drugs to the supermarket, prohibiting the sale of products made from the coca plant, including the successful energy drink from the Nasa Indian tribe, Coca Sek.
Natural coca products have been used for ages in Columbia for different remedies and to stave off hunger. The president has been promoting the natural use of coca products while magnifying the country's war on drugs with the help of U.S. aid. Lately, however, following a letter from the International Narcotics Control Board, Columbia changed its lax attitude towards the natural products as well, taking them off the shelves.
Many, of course, blame Coca-Cola Co. (NYSE: KO), saying the company was really behind this campaign as the Coca Sek started gaining popularity. Moreover, they say, why should Coca-Cola be allowed to use the extract in its drink and they shouldn't?
Coca-Cola, of course, will not reveal its secret formula and whether coke is indeed made of the coca leaves, but it is largely assumed the syrup is made from "spent" coca leaves and kola nuts. The issue was raised just two months ago as Bolivian coca growers (the plant is sacred in Bolivia) demanded copyrights on the coca name and for Coca-Cola to drop "coca" from its name.
I do find the change of heart of the Colombian president to be odd, although it's not obvious what caused it. I'm sure the whole matter, other than PR, didn't affect Coca-Cola one way or the other. Coca Sek was too small for it to worry about. And yet, is it possible Coca-Cola saw a potential risk and decided to nip the competition in the bud, before it became a threatening force?
Last updated: February 12, 2012: 04:00 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Some walnut growers want to stop selling to Diamond, Reuters says
- EASA orders Airbus A380s to be inspected, Der Spiegel says
- Sikorsky signs MOU with ASESA
- Lider Aviacao buys three Sikorsky S-92 helicopters
- Aviva won't be selling Taiwan JV stake, Reuters says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?


Reader Comments (Page 1 of 1)
5-10-2007 @ 8:30PM
C'mon said...
Aw, c'mon -- the obvious headline here is "No More Seks!"